Cellular Biomedicine Group, a subsidiary of CBMG Holdings, develops proprietary cell therapies for the treatment of cancerous and autoimmune diseases.
View Top Employees from CBMG HoldingsWebsite | https://www.cellbiomedgroup.com |
Ticker | CBMG |
Revenue | $23 million |
Funding | $120 million |
Employees | 121 (61 on RocketReach) |
Founded | 2009 |
Address | 9605 Medical Center Dr Suite 100, Rockville, Maryland 20850, US |
Phone | (347) 905-5663 |
Fax | (408) 973-7846 |
Technologies | |
Industry | Biotechnology, Biotechnology Research, Biomedicine, Science and Engineering, Progenitor Cells, Medical Device, Embryonic Stem Cells, Health Care, Dendritic Cells, Therapeutics |
Web Rank | 6 Million |
Keywords | Autoimmune Disease, Cell Therapies, Immunotherapy, Cancer Treatment, Regenerative Agriculture, Translational Medicine |
Competitors | Adaptimmune, Athersys, Promethera Biosciences, TCR² Therapeutics Inc., Tessa Therapeutics Ltd |
SIC | SIC Code 481 Companies, SIC Code 48 Companies |
NAICS | NAICS Code 5173 Companies, NAICS Code 517 Companies, NAICS Code 517312 Companies, NAICS Code 51731 Companies, NAICS Code 51 Companies |
Looking for a particular CBMG Holdings employee's phone or email?
The CBMG Holdings annual revenue was $23 million in 2024.
Tony Liu is the CEO of CBMG Holdings.
61 people are employed at CBMG Holdings.
CBMG Holdings is based in Rockville, Maryland.
The NAICS codes for CBMG Holdings are [5173, 517, 517312, 51731, 51].
The SIC codes for CBMG Holdings are [481, 48].